05-20-2011 12:24 PM CET - Health & Medicine
Print PDF Email

FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease

Press release from: FEBICO

Food that are too rich, unbalanced diets, over-nutritious, no exercise, may lead to overweight and wider waistlines. Cholesterol and triglycerides levels may rise and become higher than average, even blood pressure and blood sugar can appear higher than average, these may be a sign of a modern diseases known as Metabolic syndrome, which is also known as syndrome X.
According to the statistics in Taiwan, an average of one person out of four has the potential risk factor for cardiovascular disease. Cholesterol and high triglyceride levels are one of the main causes of hyperlipidemia and cardiovascular diseases. If not taken seriously, it will greatly increase the risk of high blood pressure, heart disease, arteriosclerosis, blood clots or strokes.
FEBICO uses special biotechnology and began in the 1990s to develop raw materials of a micro algae known as Chlorella (Chlorella Vulgaris). FEBICO has then been persistent on the production of safe, non-toxic, natural, environmentally pure, pesticide-free and uncontaminated Chlorella (Chlorella Vulgaris).
Data from animal studies from National Taiwan Ocean University, Department of Nutritional Medicine have shown that given the same diet, animals fed with FEBICO CV-66 Vulgaris for 8 weeks have much lower blood triglycerol level than the control groups without CV-66 (p

About FEBICO

FEBICO is the only company that produces organic spirulina and chlorella certified by NOP (U.S. National Organic Program) and Naturland, an IFOAM (International Federation of Organic Agricultural Movement) accredited organization.

FEBICO’s factory in Ping-Tung (southern Taiwan) produces the high quality microalgae with over 35 years of research and updated production facilities. FEBICO is the only company in the world that uses clean mountain spring water to cultivate microalgae. In Japan, 90% of microalgae is imported from Taiwan. Having 140,000 square meters culture ponds with yearly production of more than 1000 MT of microalgae, FEBICO’s company currently holds the leading position in microalgae sales with Japan in Taiwan.

Justin Hung

FEBICO(Far East Bio-Tech Co., Ltd.)
Tel: 886-2-26558198
Fax: 886-2-26558196
Email: febico@febico.com.tw
Website:
www.febico.com/
twitter.com/febicoin
febico.wordpress.com
www.facebook.com/FEBICOforBetterHealth

Justin Hung

FEBICO(Far East Bio-Tech Co., Ltd.)
Tel: 886-2-26558198
Fax: 886-2-26558196
Email: febico@febico.com.tw
Room A,13F. No.3 Yuan Chiu Street, Nangang District, Taipei 115, Taiwan
Website:
www.febico.com/
twitter.com/febicoin
febico.wordpress.com
www.facebook.com/FEBICOforBetterHealth

This release was published on openPR.
News-ID: 175924
del.icio.us:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine MisterWong:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine Digg:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine StumbleUpon:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine Technorati:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine Reddit:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine Furl:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine WebNews:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine OneView:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine LinkArena:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine YiGG:FEBICO Chlorella Vulgaris CV-66 for Preventing Metabolic Syndrome and Cardiovascular Disease - Pressreleases - openPR - Health & Medicine
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.